Medical Imaging & AI Analysis
AI-Assisted OCT Imaging for Core Needle Biopsy Guidance: The 1st in Humans Study
Author: Nicusor Iftimia et al. | Publication Date: 9 March 2026
This study introduces a combined optical imaging/artificial intelligence (OI/AI) methodology for real-time tissue morphology assessment at the tip of biopsy needles. It aims to reduce non-diagnostic biopsy cores (currently up to 40%) due to tissue heterogeneity, improving success rates and efficiency in image-guided biopsy procedures by enabling precise tissue composition determination.
Executive Impact & Key Findings
This innovative AI-assisted OCT technology promises improved diagnostic accuracy in biopsies, substantial reductions in healthcare costs by minimizing repeat procedures, and enhanced real-time decision support for clinicians. It's a significant step towards more precise and efficient treatment planning in oncology.
0
Reduction in non-diagnostic biopsies
0
AI Model Accuracy (AUC)
0
AI vs. Human Interpretation Match
Strategic Implications
- Operational Efficiency: Streamlined biopsy procedures, reduced non-diagnostic sampling.
- Patient Outcomes: More accurate tissue sampling, improved treatment planning, potentially fewer repeat invasive procedures.
- Technological Advancement: Integration of high-resolution OCT with machine learning for real-time tissue characterization.
- Cost Reduction: Minimization of repeated biopsies and associated healthcare expenditures.
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
The study introduces an innovative OI/AI methodology for real-time tissue morphology assessment at the biopsy needle tip. This process aims to enhance the accuracy of tissue sampling and reduce the incidence of non-diagnostic biopsies.
Enterprise Process Flow
Biopsy Needle Insertion (US/CT Guided)
→
Stylet Removal & OCT Needle Insertion
→
Micron-Scale OCT Imaging at Needle Tip
→
CNN-Driven AI Analysis (U-net)
→
Real-time Tissue Composition Display
→
Informed Biopsy Site Selection
The AI component utilizes a U-Net style CNN for automated analysis of OCT images. This architecture is crucial for identifying and segmenting tumorous tissue with high precision, offering real-time insights to clinicians.
Key AI Concept: U-Net CNN
A specialized U-net inspired convolutional neural network architecture was developed to segment tumor regions from OCT scans. It employs feature encoding with alternating convolutions and integrates encoded features via dense connections. The final dense layer undergoes reshaping and up-sampling to produce the segmented output.
Benefits:
- ✓ Fast and precise image segmentation.
- ✓ Classifies each pixel to outline objects.
- ✓ Streamlined for real-time results.
- ✓ Scalable for complex tissue heterogeneity.
Challenges:
- ✗ Distinguishing tumor from partially infiltrating areas remains a challenge.
- ✗ Model accuracy is influenced by the quality and representativeness of training annotations.
The study involved human participants to evaluate the technology's effectiveness in a clinical setting. The results demonstrate the strong potential of AI-assisted OCT in improving biopsy success rates and diagnostic accuracy, even with a relatively small initial dataset.
0
Patients Enrolled
0
Axial Resolution
0
Lateral Resolution
0
UNet AUC (Validation)
0
AI-Human Interpretation Match
A clinical study involving 25 patients with liver cancers evaluated the custom OCT imager and AI software. The system delivered high-quality images and demonstrated promising AI performance, with results aligning closely with human interpretations.
This comparison highlights the significant advantages of AI-assisted OCT over traditional biopsy methods, particularly in terms of real-time tissue assessment, reduced repeat biopsy rates, and overall cost-effectiveness.
| Aspect | Traditional Biopsy | AI-Assisted OCT Biopsy |
|---|---|---|
| Tissue Composition Assessment | Limited resolution (US/CT), often relies on post-biopsy histopathology | Micron-scale resolution, real-time assessment at needle tip |
| Repeat Biopsy Rate | High (up to 40% non-diagnostic cores) due to tissue heterogeneity | Potentially significantly reduced by informed site selection |
| Time to Diagnosis | Extended by histopathology analysis and potential repeat procedures | Faster due to real-time tissue characterization |
| Cost Implications | Increased costs due to repeated procedures, follow-ups | Reduced costs through improved first-pass yield and fewer repeats |
| Clinical Decision Support | Primarily post-procedure based on histopathology | Real-time guidance for optimal biopsy site selection, improved confidence |
A key benefit of this technology is its ability to navigate and overcome the complexities of heterogeneous tumor environments, ensuring that diagnostic tissue is sampled effectively from the outset.
Case Study: Targeting Heterogeneous Liver Cancer
Problem: Traditional percutaneous image-guided biopsies face challenges in acquiring adequate tissue samples due to the heterogeneous nature of cancer, often containing varying degrees of fat, necrosis, fibrosis, and tissue repair. This leads to high rates of non-diagnostic cores.
Solution: The AI-assisted OCT system provides real-time, micron-scale tissue morphology at the needle tip. In a case involving fatty liver with cancer infiltrations, the AI algorithm successfully differentiated cancerous areas, which were characterized by increased scattering due to cancer cells. This allowed for more precise targeting.
Impact: By enabling clinicians to visualize tissue composition pre-extraction, the technology helps avoid sampling benign or necrotic areas, significantly increasing the likelihood of a diagnostic yield from the first biopsy. This reduces patient burden and healthcare costs associated with repeat procedures.
Calculate Your Potential ROI
Estimate the impact of AI integration on your operational efficiency and cost savings. Adjust the parameters to reflect your enterprise.
Estimated Annual Savings
$0
Annual Hours Reclaimed
0
Your AI Implementation Roadmap
A structured approach ensures successful integration and maximum impact for your enterprise.
Phase 1: Discovery & Strategy
Initial consultation to understand current biopsy workflows, data infrastructure, and identify specific integration points for AI-assisted OCT. Define KPIs and success metrics.
Phase 2: Pilot & Customization
Deployment of a pilot AI-OCT system within a controlled clinical environment. Customization of AI models based on specific institutional data and clinical protocols, ensuring seamless integration with existing imaging systems.
Phase 3: Training & Rollout
Comprehensive training for clinical staff on AI-OCT operation and interpretation. Gradual rollout across relevant departments with continuous monitoring and support to optimize performance.
Phase 4: Optimization & Scaling
Ongoing performance review, AI model refinement, and scaling of the solution across the enterprise. Establish long-term maintenance and upgrade protocols to ensure sustained benefits.
Ready to Transform Your Diagnostic Procedures?
Connect with our AI specialists to explore how AI-assisted OCT imaging can enhance accuracy, reduce costs, and improve patient outcomes in your practice.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat